APA Citatie

Sato, Y., Nunoi, K., Kaku, K., Yoshida, A., & Suganami, H. (2019). Basal insulin secretion capacity predicts the initial response and maximum levels of beta‐hydroxybutyrate during therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin, in relation to weight loss. Diabetes Obes Metab.

Chicago Style citaat

Sato, Yuichi, Kiyohide Nunoi, Kohei Kaku, Akihiro Yoshida, en Hideki Suganami. "Basal Insulin Secretion Capacity Predicts the Initial Response and Maximum Levels of Beta‐hydroxybutyrate During Therapy With the Sodium‐glucose Co‐transporter‐2 Inhibitor Tofogliflozin, in Relation to Weight Loss." Diabetes Obes Metab 2019.

MLA citatie

Sato, Yuichi, et al. "Basal Insulin Secretion Capacity Predicts the Initial Response and Maximum Levels of Beta‐hydroxybutyrate During Therapy With the Sodium‐glucose Co‐transporter‐2 Inhibitor Tofogliflozin, in Relation to Weight Loss." Diabetes Obes Metab 2019.